Current drug therapy and pharmaceutical challenges for Chagas disease

J Bermudez, C Davies, A Simonazzi, JP Real, S Palma - Acta tropica, 2016 - Elsevier
One of the most significant health problems in the American continent in terms of human
health, and socioeconomic impact is Chagas disease, caused by the protozoan parasite …

Review on Experimental Treatment Strategies Against Trypanosoma cruzi

AL Mazzeti, P Capelari-Oliveira, MT Bahia… - Journal of …, 2021 - Taylor & Francis
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …

Anti-Trypanosoma cruzi Activity of Green Tea (Camellia sinensis) Catechins

C Paveto, MC Güida, MI Esteva… - Antimicrobial agents …, 2004 - Am Soc Microbiol
The trypanocidal action of green tea catechins against two different developmental stages of
Trypanosoma cruzi is reported for the first time. This activity was assayed with the …

In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi

CS Meira, ET Guimarães, JAF Dos Santos… - Phytomedicine, 2015 - Elsevier
Background The current treatment of Chagas disease, endemic in Latin America and
emerging in several countries, is limited by the frequent side effects and variable efficacy of …

In vitro activity and mutagenicity of bisbenzylisoquinolines and quinones against Trypanosoma cruzi trypomastigotes

AR de Arias, A Inchausti, M Ascurrat… - Phytotherapy …, 1994 - Wiley Online Library
The accidental transmission of Chagas' disease by donor blood is recognized as a serious
problem in the Latin America. This paper describes the screening of natural products as …

Experimental chemotherapy and approaches to drug discovery for Trypanosoma cruzi infection

FS Buckner - Advances in parasitology, 2011 - Elsevier
In the 100 years since the discovery of Chagas disease, only two drugs have been
developed and introduced into clinical practice, and these drugs were introduced over 40 …

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity

B Zingales, MA Miles, CB Moraes, A Luquetti… - Memórias do Instituto …, 2014 - SciELO Brasil
This opinion piece presents an approach to standardisation of an important aspect of
Chagas disease drug discovery and development: selecting Trypanosoma cruzi strains for …

The urgent need to develop new drugs and tools for the treatment of Chagas disease

MJ Muñoz, L Murcia, M Segovia - Expert review of anti-infective …, 2011 - Taylor & Francis
Chagas disease, also known as American trypanosomiasis, is caused by the protozoan
parasite Trypanosoma cruzi, which was discovered by the Brazilian Carlos Chagas in 1909 …

Chagas disease: progress and new perspectives

F Sanchez-Sancho, NE Campillo… - Current Medicinal …, 2010 - ingentaconnect.com
Chagas disease, also known as American trypanosomiasis, is caused by infection with the
protozoan parasite Trypanosoma cruzi. The Pan American Health Organization (PAHO) …

[HTML][HTML] Screening of potential anti-Trypanosoma cruzi candidates: in vitro and in vivo studies

CS Maria de Nazaré, SL de Castro - The Open Medicinal …, 2011 - ncbi.nlm.nih.gov
Chagas disease (CD), caused by the intracellular protozoan Trypanosoma cruzi, is a
parasitic illness endemic in Latin America. In the centennial after CD discovery by Carlos …